» Articles » PMID: 35027642

Post-stroke Treatment with Argon Preserved Neurons and Attenuated Microglia/macrophage Activation Long-termly in a Rat Model of Transient Middle Cerebral Artery Occlusion (tMCAO)

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jan 14
PMID 35027642
Authors
Affiliations
Soon will be listed here.
Abstract

In a previous study from our group, argon has shown to significantly attenuate brain injury, reduce brain inflammation and enhance M microglia/macrophage polarization until 7 days after ischemic stroke. However, the long-term effects of argon have not been reported thus far. In the present study, we analyzed the underlying neuroprotective effects and potential mechanisms of argon, up to 30 days after ischemic stroke. Argon administration with a 3 h delay after stroke onset and 1 h after reperfusion demonstrated long-term neuroprotective effect by preserving the neurons at the ischemic boundary zone 30 days after stroke. Furthermore, the excessive microglia/macrophage activation in rat brain was reduced by argon treatment 30 days after ischemic insult. However, long-lasting neurological improvement was not detectable. More sensorimotor functional measures, age- and disease-related models, as well as further histological and molecular biological analyses will be needed to extend the understanding of argon's neuroprotective effects and mechanism of action after ischemic stroke.

Citing Articles

Positive Effects of Argon Inhalation After Traumatic Brain Injury in Rats.

Antonova V, Silachev D, Plotnikov E, Pevzner I, Ivanov M, Boeva E Int J Mol Sci. 2024; 25(23).

PMID: 39684384 PMC: 11640893. DOI: 10.3390/ijms252312673.


Long lasting argon neuroprotection in a non-human primate model of transient endovascular ischemic stroke.

Gonzalez Torrecilla S, Delbrel A, Giacomino L, Meunier D, Sein J, Renaud L J Cereb Blood Flow Metab. 2024; :271678X241297798.

PMID: 39628320 PMC: 11615904. DOI: 10.1177/0271678X241297798.


Argon mitigates post-stroke neuroinflammation by regulating M1/M2 polarization and inhibiting NF-κB/NLRP3 inflammasome signaling.

Xue K, Qi M, She T, Jiang Z, Zhang Y, Wang X J Mol Cell Biol. 2022; 14(12).

PMID: 36574951 PMC: 10165685. DOI: 10.1093/jmcb/mjac077.

References
1.
Antonov A, Ershova T . [Retention of the skill to perform adaptive bio-control of bioelectrical activity synchronization in the human brain cortex in an argon-nitrogen-oxygen atmosphere with various oxygen content]. Aviakosm Ekolog Med. 2010; 43(5):27-31. View

2.
Iadecola C, Anrather J . The immunology of stroke: from mechanisms to translation. Nat Med. 2011; 17(7):796-808. PMC: 3137275. DOI: 10.1038/nm.2399. View

3.
Ulbrich F, Lerach T, Biermann J, Kaufmann K, Lagreze W, Buerkle H . Argon mediates protection by interleukin-8 suppression via a TLR2/TLR4/STAT3/NF-κB pathway in a model of apoptosis in neuroblastoma cells in vitro and following ischemia-reperfusion injury in rat retina in vivo. J Neurochem. 2016; 138(6):859-73. DOI: 10.1111/jnc.13662. View

4.
Ma Y, Wang J, Wang Y, Yang G . The biphasic function of microglia in ischemic stroke. Prog Neurobiol. 2016; 157:247-272. DOI: 10.1016/j.pneurobio.2016.01.005. View

5.
Loetscher P, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A . Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care. 2009; 13(6):R206. PMC: 2811924. DOI: 10.1186/cc8214. View